Copyright
©The Author(s) 2017.
World J Biol Chem. Feb 26, 2017; 8(1): 81-85
Published online Feb 26, 2017. doi: 10.4331/wjbc.v8.i1.81
Published online Feb 26, 2017. doi: 10.4331/wjbc.v8.i1.81
Stage of disease | Serum TG level | Uses and further action | ||
Low | Normal | Elevated | ||
Before surgery | Anti-TGAb or TG non-secreting tumour | TG can not be used subsequently to monitor disease activity | ||
Benign or malignant thyroid disease | TG can be used subsequently to monitor disease activity | |||
3-4 wk after surgery | Anti-TGAb, successful local surgery or no metastatic disease | Do 125-Iodine scan to screen for residual local disease and distant metastases | ||
Incomplete local surgery, metastatic disease or recurrence | Remnant ablation therapy (131-Iodine or further surgery) is indicated | |||
Long term follow-up | Anti-TGAb | Do other tests to monitor disease activity | ||
Cure or stable disease | Disease activity can be monitored by periodic TG measurements | |||
Recurrence or progression | Further investigations and treatment |
- Citation: Indrasena BSH. Use of thyroglobulin as a tumour marker. World J Biol Chem 2017; 8(1): 81-85
- URL: https://www.wjgnet.com/1949-8454/full/v8/i1/81.htm
- DOI: https://dx.doi.org/10.4331/wjbc.v8.i1.81